Skip to content

Breath Analysis by Ion Mobility Spectrometry

Detection of Clusters of Volatile Organic Compounds (VOC)in Patients With Different Lung Disorders by Ion Mobility Spectrometry. Different Clusters of VOC in the Diagnosis of Different Lung Disorders Using Ion Mobility Spectrometry

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00632307
Enrollment
1000
Registered
2008-03-10
Start date
2006-07-31
Completion date
2023-12-31
Last updated
2022-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Diseases

Keywords

lung tumor, pleural tumor, interstitial lung disease, airway infection, COPD, sleep apnea, ion mobility spectrometry, breath analysis

Brief summary

Recognition of disease specific clusters of volatile organic compounds in patients with different lung diseases, using breath analysis with ion mobility spectrometry. Lung diseases of interest are: * COPD * tumors * airway infection * interstitial lung disease * sleep apnea Hypothesis: Breath analysis with ion mobility spectrometry can differentiate pulmonary disorders.

Detailed description

Recruitment of patients with different lung diseases goes on. First sub-group analysis of patients with COPD,lung cancer and sarcoidosis is done in order to create a training set of VOC-clusters for further validation in a bigger population of patients.

Interventions

None listed

Sponsors

Lung Clinic Hemer
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* Any patient * Ages 18-90 years old

Exclusion criteria

\- Patient who are not able to perform an exhalation manoever.

Design outcomes

Primary

MeasureTime frame
Identification of diseases specific VOCsyears

Secondary

MeasureTime frame
Change of disease specific VOCs under therapyyears

Countries

Germany

Contacts

Primary ContactMichael Westhoff, MD
michael.westhoff@lkhemer.de004923729082203
Backup ContactPatric Litterst, MD
pneumologie@lkhemer.de004923729082545

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026